Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Early coverage scheme for digital medical devices and medical telemonitoring solutions launched in France

25 Apr 2023

On March 31, 2023, the Ministry of Health and Prevention published the Decree in the Official Journal of the French Republic that defines an application process for the early coverage of digital medical devices for therapeutic purposes and medical telemonitoring by health insurance.

Early coverage of digital technologies (PECAN) as a part of the “Digital Health” acceleration strategy allows temporary coverage by the health insurance of presumably innovative digital medical devices for therapeutic purposes (intended to be included on the list of reimbursable products and services, LPPR) or for medical telemonitoring (intended to be registered on the new list of medical telemonitoring activities, LATM).

The temporary coverage is provided for one year with the requirement that companies provide the data necessary for the evaluation of their medical device and that the latter already complies with safety requirements. The whole process of including the technology under early coverage lasts no more than 90 days (60 days for the assessment by the Digital Health Agency (ANS) and the National Authority for Health (HAS) and 30 days for the decision by the Ministry of Health).

When the early coverage is established, manufacturers of digital medical devices for therapeutic purposes have six months to apply for the registration of their device in the LPPR. Manufacturers of medical telemonitoring solutions have to apply for reimbursement through LATM during nine months from the start of the early coverage.

See the details in French here (Ministerial Decree) and here (HAS).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).